UnitedHealth Group and Amedisys outlined plans to divest a significant number of home health and hospice locations as they ...
Recent developments in the legal battle over the planned $3.3 billion UnitedHealth Group (NYSE: UHG) acquisition of Amedisys (Nasdaq: AMED) have moved the ...
UnitedHealth Group says the Justice Department’s antitrust challenge to its proposed $3.3 billion purchase of Amedisys is wrong ... sharper competition in the hospice and home care market.
UnitedHealth Group has been battling for nearly 20 months to complete its $3.3 billion all-cash bid to buy Amedisys. UnitedHealth Group operates home health and hospice locations in 37 markets ...
In the complaint, the government said that if UnitedHealth’s acquisition of Amedisys went through, UnitedHealth would control more than 30% of the home health or hospice services in eight states.
Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity ... s highest honors. “Every day, our employees bring warmth ...
In a report released on January 29, Whit Mayo from Leerink Partners reiterated a Hold rating on Amedisys (AMED – Research Report), with a price ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback